Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCORE: Triamcinolone for Macular Edema in RVO
NCT00105027Phase 3Completed
- Sponsor
- Emmes
- Start
- Oct 2004
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in macular edema, sponsored by Emmes. Started Oct 2004; status: completed.
02
Drugs
triamcinolone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00105027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105027.